Tilapia is an important source of dietary protein, especially in developing countries. Massive losses of tilapia were identified worldwide, risking the food security of millions of people.
RNA viruses are particularly notorious for their high levels of genetic diversity, which is generated through the forces of mutation and natural selection. However, disentangling these two forces is a considerable challenge, and this may lead to widely divergent estimates of viral mutation rates, as well as difficulties in inferring fitness effects of mutations. Here, we develop, test, and apply an approach aimed at inferring the mutation rate and key parameters that govern natural selection, from haplotype sequences covering full-length genomes of an evolving virus population. Our approach employs neural posterior estimation, a computational technique that applies simulation-based inference with neural networks to jointly infer multiple model parameters. We first tested our approach on synthetic data simulated using different mutation rates and selection parameters while accounting for sequencing errors. Reassuringly, the inferred parameter estimates were accurate and unbiased. We then applied our approach to haplotype sequencing data from a serial-passaging experiment with the MS2 bacteriophage, a virus that parasites Escherichia coli. We estimated that the mutation rate of this phage is around 0.2 mutations per genome per replication cycle (95% highest density interval: 0.051-0.56). We validated this finding with two different approaches based on single-locus models that gave similar estimates but with much broader posterior distributions. Furthermore, we found evidence for reciprocal sign epistasis between four strongly beneficial mutations that all reside in an RNA stem-loop that controls the expression of the viral lysis protein, responsible for lysing host cells and viral egress. We surmise that there is a fine balance between over- and under-expression of lysis that leads to this pattern of epistasis. To recap, we have developed an approach for joint inference of the mutation rate and selection parameters from full haplotype data with sequencing errors and used it to reveal features governing MS2 evolution.
26 June 2026 in The Journal of Infectious Diseases
Background: Herpes simplex virus (HSV) type 1 and 2 infect over 14,000 newborns each year globally, with most cases (55%) causing a severe outcome that can be fatal if untreated. Neonatal disease severity and long-term outcomes remain unpredictable, and elucidating viral factors that contribute to these outcomes remains a challenge. However, through viral genomic and phenotypic analysis of HSV isolated from neonatal patients, we can begin to connect aspects of viral diversity with clinical patient data. Methods: Here we have applied viral whole genome sequencing to a collection of residual clinical diagnostic samples from ten neonates who had either mild or severe HSV-1 infections. Samples from different body sites or across recurrences allowed for both within- and between-host comparisons. From 30 residual diagnostic samples, we successfully isolated 14 viral cultures. These cultured viruses enabled additional phenotypic analyses, including in vitro growth evaluation in multiple cell types and an in vivo murine model of infection. Results: These data highlight the diversity found in HSV-1 isolated from neonates. Through comparative genomics approaches, we demonstrate both within- and between-host diversity of these samples. Growth of cultured isolates in cell-based assays and a murine model of infection reveal additional aspects of within- and between-host differences. Conclusions: Overall, this study presents the first investigation into the viral diversity of neonatal HSV-1, which is now more common in the US than neonatal HSV-2. Through integration of phenotypic, genomic, and clinical data we characterized these neonatal viral samples to begin unraveling the complexity of neonatal HSV-1 infections.
24 July 2026 in Journal of the Pediatric Infectious Diseases Society
Neonatal herpes simplex virus disease most often occurs following mother-to-neonate transmission during childbirth. However, genomic differences between the maternal and neonatal viral populations are poorly understood. Here, we performed deep whole-genome sequencing of clinical HSV-2 samples obtained from a maternal-neonatal dyad to investigate viral population dynamics during transmission.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a severe global pandemic. Mice models are essential to investigate infection pathology, antiviral drugs, and vaccine development. However, wild-type mice lack the human angiotensin-converting enzyme 2 (hACE2) that mediates SARS-CoV-2 entry into human cells and consequently are not susceptible to SARS-CoV-2 infection. hACE2 transgenic mice could provide an efficient COVID-19 model, but are not always readily available, and practically restricted to specific strains. Therefore, there is a dearth of additional mouse models for SARS-CoV-2 infection. We applied lentiviral vectors to generate hACE2 expression in interferon receptor knock-out (IFNAR1−/−) mice. Lenti-hACE2 transduction supported SARS-CoV-2 replication in vivo, simulating mild acute lung disease. Gene expression analysis revealed two modes of immune responses to SARS-CoV-2 infection: one in response to the exposure of mouse lungs to SARS-CoV-2 particles in the absence of productive viral replication, and the second in response to productive SARS-CoV-2 infection. Our results infer that immune response to immunogenic elements on incoming virus or in productively infected cells stimulate diverse immune effectors, even in absence of type I IFN signaling. Our findings should contribute to a better understanding of the immune response triggered by SARS-CoV-2 and to further elucidate COVID-19.
About Me
PhD student at TAU. Research field: molecular virology.
PhD student at TAU. Research field: molecular virology.